Tryp Therapeutics Inc.
OTC: TRYPF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jason Carroll
- Headquarters
- Kelowna, Canada
- IPO year
- 2021
- Market cap
- $5.4M
- Website
- https://www.tryptherapeutics.com
Loading TRYPF…
Loading profile data…Frequently asked questions about TRYPF
What does Tryp Therapeutics Inc. (TRYPF) do?
Tryp Therapeutics Inc. is a biopharmaceutical company dedicated to identifying and advancing novel therapeutic compounds for medical conditions characterized by significant unmet needs. Its flagship development initiative, known as PFN, focuses on addressing neuropsychiatric disorders by utilizing precisely formulated synthetic psilocybin. Withi...
Where does TRYPF trade?
Tryp Therapeutics Inc. (TRYPF) trades on the Other OTC.
What sector is TRYPF in?
Tryp Therapeutics Inc. (TRYPF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Tryp Therapeutics Inc.?
Jason Carroll is the chief executive officer of Tryp Therapeutics Inc. (TRYPF).
Where is Tryp Therapeutics Inc. headquartered?
Tryp Therapeutics Inc. is headquartered in Canada.
Does TRYPF pay a dividend?
Tryp Therapeutics Inc. (TRYPF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TRYPF go public?
Tryp Therapeutics Inc. (TRYPF) completed its initial public offering in 2021.